Factors in the Generic "Ripple Effect"

Judith Kulich

Approximately 30 branded pharmaceutical products have or will come off patent between 2010 and 2012. These patent losses have implications for the branded drugs, but also for many of their competitors. These implications involve the effect of generic launch on overall market dynamics and what pharmaceutical companies can do to anticipate these effects.

> Download